<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=iso-8859-1"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
span.EmailStyle20
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.EmailStyle21
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:869415668;
mso-list-type:hybrid;
mso-list-template-ids:-2106560304 269025295 269025305 269025307 269025295 269025305 269025307 269025295 269025305 269025307;}
@list l0:level1
{mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level2
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level3
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
text-indent:-9.0pt;}
@list l0:level4
{mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level5
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level6
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
text-indent:-9.0pt;}
@list l0:level7
{mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level8
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level9
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
text-indent:-9.0pt;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>See below for a link to interesting info wrt PCa.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Also attached are 2 upcoming events.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Take care,<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Anne Breakey Hart [mailto:anne.breakeyhart@prostatecancer.ca] <br><b>Sent:</b> September 12, 2017 2:11 PM<br><b>To:</b> anne.breakeyhart@prostatecancer.ca<br><b>Subject:</b> For Your Information<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Hello everyone,<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>I want to share with you these interesting items about prostate cancer that have come to our attention this summer:<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Special thanks to Paul Wilkinson from PCCN Montreal West Island who graciously worked his magic for all the groups across the country to receive the digital copy below.<o:p></o:p></p><p class=MsoNormal>And to Annika Parance, Éditeur for her generous gift of digital access to the fourth edition of the following:<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><b>Prostate Cancer: Understand the Disease and Its Treatment revised and expanded by Fred Saad, M.D. and Michael McCormack, M.D. <o:p></o:p></b></p><p class=MsoNormal>See the link below. <b>Please note that the link allows users to browse only, not download.<o:p></o:p></b></p><p class=MsoNormal>You can browse in both English or French by following the instructions on the main page.<o:p></o:p></p><p class=MsoNormal><a href="https://www.entrepotnumerique.com/campaigns/L2HBUbsFPkRqWKrN">https://www.entrepotnumerique.com/campaigns/L2HBUbsFPkRqWKrN</a><o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Thank you to Glen Tolhurst from PCCN Waterloo-Wellington for sharing this article which came out in August – you may have seen in on some of PCC’s social pages and, or PCC staff pages.<o:p></o:p></p><p class=MsoNormal><a href="http://www.cancernetwork.com/prostate-cancer/analysis-major-prostate-cancer-screening-trials-agree-mortality-reduction">http://www.cancernetwork.com/prostate-cancer/analysis-major-prostate-cancer-screening-trials-agree-mortality-reduction</a><o:p></o:p></p><p class=MsoNormal><b><o:p> </o:p></b></p><p class=MsoNormal><b><o:p> </o:p></b></p><p class=MsoNormal><b>And attached – coming up soon:<o:p></o:p></b></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoListParagraph style='text-indent:-18.0pt;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'> </span></span><![endif]>Sept 21 – evening - Annual conference Groupe de soutien du cancer de la prostate du CHUM in Montreal (Dr. Saad is a main speaker)<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoListParagraph style='text-indent:-18.0pt;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'> </span></span><![endif]>October 3rd – 1-2 pm Eastern - Osteoporosis and Cancer webinar – although not directly focussed on prostate cancer should be very interesting learning<o:p></o:p></p><p class=MsoListParagraph><o:p> </o:p></p><p class=MsoNormal>Please note that as per usual by sharing this information Prostate Cancer Canada takes no responsibility for the information provided or any information including contact info. that you may provide to the parties involved.<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Many thanks, Anne<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>Anne Breakey Hart, CVA<br></span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>Manager, PCCN and Volunteer Engagement | Prostate Cancer Canada<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>Gestionnaire,</span><span lang=EN-US style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0067B1'> Mobilisation des bénévoles </span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>| Cancer de la Prostate Canada</span><span lang=EN-US style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0067B1'><o:p></o:p></span></p><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>T </span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>416-441-2131 ext./poste 229 | <b>E</b></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0067B1'> </span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#1F497D'><a href="mailto:anne.breakeyhart@prostatecancer.ca">anne.breakeyhart@prostatecancer.ca</a></span><span style='color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><a href="www.prostatecancer.ca">www.prostatecancer.ca</a><o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><img border=0 width=250 height=93 id="Picture_x0020_4" src="cid:image001.png@01D32BC4.F6B9C330" alt="cid:image001.png@01D06C88.6A54F890"><o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><a href="http://www.facebook.com/prostatecancercanada"><span style='text-decoration:none'><img border=0 width=24 height=24 id="Picture_x0020_3" src="cid:image002.png@01D32BC4.F6B9C330" alt=facebook></span></a><span style='color:#1F497D'> </span><a href="http://www.twitter.com/prostatecancerc"><span style='text-decoration:none'><img border=0 width=24 height=24 id="Picture_x0020_2" src="cid:image003.png@01D32BC4.F6B9C330" alt=twitter></span></a><span style='color:#1F497D'> </span><a href="youtube.com/prostatecancercanada"><span style='text-decoration:none'><img border=0 width=24 height=24 id="Picture_x0020_1" src="cid:image004.png@01D32BC4.F6B9C330" alt=Youtube></span></a><o:p></o:p></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#0070C0'>September is Prostate Cancer Awareness Month. Prostate cancer is the most common cancer to affect Canadian men, <b>with</b> <b>1 in 7 men diagnosed in their lifetime</b>. </span><span lang=FR-CA style='color:#0070C0'>Learn more at </span><span style='color:#1F497D'><a href="http://www.prostatecancer.ca/AwarenessMonth"><span lang=FR-CA>prostatecancer.ca/AwarenessMonth</span></a></span><span lang=FR-CA style='color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><span lang=FR-CA style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span lang=FR-CA style='color:#0070C0'>Septembre est le mois de la sensibilisation au cancer de la prostate. Ce cancer est le plus répandu chez les hommes au Canada : <b>un homme sur sept en recevra le diagnostic au cours de sa vie</b>. </span><span style='color:#0070C0'>Renseignez-vous à</span><span style='color:#1F497D'> <a href="http://prostatecancer.ca/Get-Involved/Events/Prostate-Cancer-Awareness-Month?lang=fr-CA"><span lang=FR-CA>prostatecancer.ca/MoisdelaSensibilisation</span></a></span><span lang=FR-CA style='color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=FR-CA style='color:#0070C0'><o:p> </o:p></span></p><p class=MsoNormal><span lang=FR-CA><o:p> </o:p></span></p><p class=MsoNormal><span lang=FR-CA><o:p> </o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span lang=FR-CA><o:p> </o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p></div></body></html>